LAUSR

Sir, we report here a rare case of IgG4-related hypertrophic pachymeningitis which formed a symmetrical focal mass lesion in the clivus region. A 51-year-old male was admitted to our hospital complaining of eye movement disorder. His consciousness level was clear and neurological examinations revealed no abnormalities except for bilateral abducens nerve palsies (Fig. 1a–c). He was engaged in general desk work and had no occupational and/or medical history which could be a risk factor for any disease. Magnetic resonance (MR) imaging disclosed a symmetrical mass lesion in the clivus region, which displayed iso-intensity on T1-weighted MR imaging, and low-intensity on T2-weighted MR imaging; also, homogenous enhancement was evident after contrast medium administration, and the mass lesion retracted the patient’s pons (Fig. 2a). Cerebral angiography revealed arterial supply via the bilateral meningohypophyseal trunk. Laboratory investigations including those for tumor markers did not yield any abnormal values, and no neoplastic lesions were found in other organs on computed tomography scans. The lesion was preoperatively diagnosed as a clivus meningioma. The patient underwent surgical removal via a left-side anterior petrosal approach to remove the left-side mass. The intraoperative findings indicated that the mass was situated between the abducens nerve and pons. Removal of the mass proved very difficult because the tumor was very hard and tightly attached to the pons. To make a diagnosis and to avoid critical complications, the mass was removed partially. Pathological examinations including immunohistochemical staining demonstrated the presence of abundant IgG positive plasma cells resting on fibrous tissue. These cells also exhibited positive expression of IgG4, and the ratio was 15.2% of the positive expression of IgG (Fig. 2d–f). The above pathological findings were consistent with IgG4-related hypertrophic pachymeningitis. The patient’s postoperative course was uneventful, and postoperative MR imaging demonstrated residual majority of the mass lesion (Fig. 2b). The peripheral blood IgG (885 mg/dl; reference range 861–1747 mg/dl) and IgG4 (66.7 mg/dl; reference range 4.8–105 mg/dl) were estimated postoperatively, and these levels were normal. Furthermore, evaluations of the peripheral blood PR3-ANCA, MPO-ANCA, anti-nuclear antibody, dsDNA, C3, C4, CH50, soluble interleukin-2 receptor, CD4 and CD8 were made; however, all of the values were negative or within the normal range. The patient underwent glucocorticoid treatment. Prednisolone was started at 60 mg/day to finish by tapering every 14 days after 1000 mg methylprednisolone for 3 days (the total glucocorticoid treatment period was 87 days). The patient’s bilateral abducens nerve palsies were particularly improved after the glucocorticoid treatment (Fig. 1d–f). The mass lesion disappeared completely on post glucocorticoid treatment MR imaging (Fig. 2c), and recurrence has not been recognized even though more than 5 years have passed without any further medication including glucocorticoid. IgG4-related hypertrophic pachymeningitis is being increasingly recognized, but a consensus concerning the optimal diagnostic approach and therapeutic approach remains lacking [1]. Hypertrophic pachymeningitis usually exhibits a diffusely invasive pattern, but rarely demonstrates a focal mass as in the present case or in a few other case reports [2–5]. When hypertrophic pachymeningitis reveals a focal mass, it is difficult to distinguish from a tumor, such as meningioma and/or solitary fibrous tumor, preoperatively [2, 4, 5]. Tang et al. reported a case of clivus massive IgG4-related disease similar to the present case [5]. In their report, the mass was preoperatively * Shun Yamamuro [email protected]